Challenges in the Use of Targeted Therapies in Non–Small Cell Lung Cancer
Joel Rivera-Concepcion, Dipesh Uprety, Alex A. Adjei
Cancer Res Treat. 2022;54(2):315-329.   Published online 2022 Feb 18     DOI: https://doi.org/10.4143/crt.2022.078
Citations to this article as recorded by Crossref logo
Prognostic score and sex-specific nomograms to predict survival in resectable lung cancer: A French nationwide study from the Epithor cohort database
Marco Alifano, Elisa Daffré, Laurent Brouchet, Pierre Emmanuel Falcoz, Françoise Le Pimpec Barthes, Pierre Benoit Pages, Pascal Alexandre Thomas, Marcel Dahan, Raphael Porcher
The Lancet Regional Health - Europe.2023; 26: 100566.     CrossRef
Novel Biomarkers in Lung Cancer and Chronic Lung Diseases: From the Systematic Perspective of Yin–Yang Balance
Mi-Kyung Jeong, Jaemoo Chun, In-Jae Oh
Journal of Clinical Medicine.2022; 11(15): 4275.     CrossRef
Application of Perinatal Derivatives on Oncological Preclinical Models: A Review of Animal Studies
Ricardo Teixo, Ana Salomé Pires, Eurico Pereira, Beatriz Serambeque, Inês Alexandra Marques, Mafalda Laranjo, Slavko Mojsilović, Roberto Gramignoli, Peter Ponsaerts, Andreina Schoeberlein, Maria Filomena Botelho
International Journal of Molecular Sciences.2022; 23(15): 8570.     CrossRef
Survival benefit of thermal ablation therapy for patients with stage II-III non-small cell lung cancer: A propensity-matched analysis
Wei-Yu Yang, Yu He, Qikang Hu, Muyun Peng, Zhe Zhang, Shouzhi Xie, Fenglei Yu
Frontiers in Oncology.2022;[Epub]     CrossRef
Molecular targeted therapy for anticancer treatment
Hye-Young Min, Ho-Young Lee
Experimental & Molecular Medicine.2022; 54(10): 1670.     CrossRef
Transcriptomic FHITlow/pHER2high signature as a predictive factor of outcome and immunotherapy response in non-small cell lung cancer
Audrey Brisebarre, Julien Ancel, Théophile Ponchel, Emma Loeffler, Adeline Germain, Véronique Dalstein, Valérian Dormoy, Anne Durlach, Gonzague Delepine, Gaëtan Deslée, Myriam Polette, Béatrice Nawrocki-Raby
Frontiers in Immunology.2022;[Epub]     CrossRef
CIGB-300 Anticancer Peptide Differentially Interacts with CK2 Subunits and Regulates Specific Signaling Mediators in a Highly Sensitive Large Cell Lung Carcinoma Cell Model
George V. Pérez, Mauro Rosales, Ailyn C. Ramón, Arielis Rodríguez-Ulloa, Vladimir Besada, Luis J. González, Daylen Aguilar, Dania Vázquez-Blomquist, Viviana Falcón, Evelin Caballero, Paulo C. Carvalho, Rodrigo Soares Caldeira, Ke Yang, Yasser Perera, Silv
Biomedicines.2022; 11(1): 43.     CrossRef